Alpenglow News & Updates
Alpenglow Biosciences and CorePlus partner together to bring 3D Spatial Biology to clinical research and development
Alpenglow Biosciences Unveils Fully Integrated “3Deep” Offering at BIO2022 Bringing AI-Powered, 3D Insights to Spatial Biology
Nature Methods perspective article describes how Alpenglow's 3Deep Imager makes 'imaging cleared tissues easy'
Alpenglow Co-Founders in the Latest Publication of Nature Methods
Lightspeed Microscopy, Inc. Rebrands as Alpenglow Biosciences
Lightspeed Microscopy, Inc., developers of an innovative end-to-end 3D spatial biology platform, has announced today that the company will begin operating under the new name Alpenglow Biosciences, effective immediately.
Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology
Lightspeed Microscopy, Inc., an end-to-end 3D pathology platform, announced today it has raised $4 million in a Series A financing round. The round was led by Dynamk Capital and is expected to close with participation from additional investors by mid-July.
Alpenglow (Formerly Lightspeed Microscopy) featured in NIH Director’s Blog
NIH Director Dr. Francis Collins posts a blog featuring the early work by CEO Nicholas (Nick) Reder MD MPH, then medical resident in the pathology department at the University of Washington, and Dr. Jonathan Liu of the mechanical engineering department that was inspired by a technical challenge.